Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, PET

CUBEX LLC introduces CUBEX Mini, a revolutionary device for storage and management of controlled substances in veterinary medicine


PHOENIX, June 14, 2018 /PRNewswire/ -- CUBEX LLC, the leading provider of pharmacy and supply management technology to the animal health market, announced the introduction CUBEX® Mini, a solution for veterinarians looking to reduce the legal and financial risks associated with controlled substances. Using patented CUBIE technology, CUBEX Mini is the industry's first device to offer automated, biometric, DEA-compliant safeguards for storage of narcotics and other medications, alongside bi-directional integration with most practice software systems, all in a device that fits on a standard counter top and is available through a subscription, no capital purchase required.

At Cubex, we are united in our vision to improve efficiencies for our customers. We are passionate about healthcare and helping those who deliver it by providing sophisticated solutions that allow them to focus their time on patient care.

"The DEA is putting animal practices under more scrutiny than ever, thanks to the opioid epidemic." said Anton Visser, co-founder and CEO of CUBEX. "At the same time, the animal health industry has been growing rapidly, and when things get busy, people are tempted to take shortcuts. CUBEX Mini automates the tasks required for controlled substances management, which saves the practice time and money, and ensures everyone stays in compliance with the law."

Controlled drugs are rated in the order of their potential for abuse and placed in Schedules by the Drug Enforcement Administration (DEA), from schedules II-V. Many drugs used in veterinary medicine fall within a DEA schedule, and there are numerous registration, storage and record-keeping requirements for veterinarians to navigate in order to legally use them.

Amid an increase in opiod abuse nationally, diversion of drugs such as tramadol and fentanyl by veterinary employees has attracted the attention of the DEA, leading to an uptick in audit frequency. Additionally, an increasing number of state-run PMPs (Prescription Management Programs) have expanded their requirements to include veterinarians, adding an additional reporting burden.

"Before we got CUBEX Mini, maintaining controlled substances was a real time drain, and there was always the risk that we'd miss a requirement." said Dr. Curt Coffman, owner of Arizona Veterinary Dental Specialists. "DEA fines start at over $14,000 per infraction, so that gets expensive quickly. I also knew that sometimes, charges from the pharmacy were missed, and we were dispensing meds no one had paid for. Now I know we're doing things the right way. CUBEX Mini keeps everything safe and makes sure each transaction is recorded, including the client charge. That helps us sleep a little better."

CUBEX Mini is available now through a simple monthly subscription. Visit info.cubex.biz/mini to learn more, or call 480-470-3284 to schedule a demo.

Media Contact:
Joey Campagna (CUBEX LLC)
(480) 268-7955
[email protected]

CUBEX Mini is a compact, affordable solution for DEA-compliant storage, dispensing and management of controlled substances within the veterinary practice. In just seconds, your staff can access the medications your patients need and have all transactions automatically recorded, without fumbling with keys or manual logbooks. Fingerprint ID for every transaction assures accountability, and reports are generated on demand.

SOURCE CUBEX LLC


These press releases may also interest you

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:00
Driving is the leading cause of work-related death each year in the United States, with nearly 40% of deaths on the job occurring on American roads according to the U.S. Bureau of Labor Statistics. A major contributing factor to road deaths each...

at 10:00
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according...

at 10:00
NastLaw LLC announces: If you purchased certain named generic pharmaceutical drugs directly from certain pharmaceutical manufacturers from May 1, 2009 through December 31, 2019, your rights may be affected by proposed class action settlements.A...

at 09:48
Perspire Sauna Studio, one of the country's largest sauna franchises specializing in full spectrum infrared (IR) and red-light therapy (RLT), is rolling out a new sauna design and member experience through the brand's long-standing partnership with...



News published on and distributed by: